reviewChemical Society ReviewsJan 1, 2015Closed access

Facts and fictions about polymorphism

Roche (Switzerland) · Eli Lilly (United States) · +5 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

We present new facts about polymorphism based on (i) crystallographic data from the Cambridge Structural Database (CSD, a database built over 50 years of community effort), (ii) 229 solid form screens conducted at Hoffmann-La Roche and Eli Lilly and Company over the course of 8+ and 15+ years respectively and (iii) a dataset of 446 polymorphic crystals with energies and properties computed with modern DFT-d methods. We found that molecular flexibility or size has no correlation with the ability of a compound to be polymorphic. Chiral molecules, however, were found to be less prone to polymorphism than their achiral counterparts and compounds able to hydrogen bond exhibit only a slightly higher propensity to…

No related works found for this paper.

Funding